首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparison of SCH 39304 and its isomers RR 42427 and SS 42426 for treatment of murine cryptococcal and coccidioidal meningitis.
【2h】

Comparison of SCH 39304 and its isomers RR 42427 and SS 42426 for treatment of murine cryptococcal and coccidioidal meningitis.

机译:SCH 39304及其异构体RR 42427和SS 42426在治疗鼠类隐球菌和球虫性脑膜炎中的比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

SCH 39304 (304) and its isomers, SCH 42426 (426) and SCH 42427 (427), are new orally administered antifungal azole derivatives. In this study, we compared the efficacy of 304 with that of 426 and 427 in murine models of cryptococcal and coccidioidal meningitis. On day 18 postinfection with Cryptococcus neoformans, controls showed 80% mortality. The 50% protective doses calculated at this day were 0.56 mg of 304 per kg of body weight, 23.5 mg of 426 per kg, and 0.11 mg of 427 per kg. Controls with coccidioidal meningitis all succumbed, and treated mice at the same time point showed 50% protective doses of 10.8 mg/kg for 304, 200 mg/kg for 426, and 2.1 mg/kg for 427. We conclude that isomer 427 is five times as potent, whereas 426 is 1/50th as potent as 304 in these experimental mycoses.
机译:SCH 39304(304)及其异构体SCH 42426(426)和SCH 42427(427)是口服的新型抗真菌唑衍生物。在这项研究中,我们在隐球菌和球虫性脑膜炎的小鼠模型中比较了304和426和427的疗效。在用新型隐球菌感染后的第18天,对照组显示出80%的死亡率。当天计算出的50%保护剂量为0.56 mg 304 / kg体重,23.5 mg 426 / kg体重和0.11 mg 427 / kg体重。球虫性脑膜炎的对照均被屈服,并且在同一时间点接受治疗的小鼠显示50%的保护剂量分别为304的10.8 mg / kg,426的200 mg / kg和427的2.1 mg / kg。我们得出的异构体427是五个在这些实验性真菌病中,效力是304的两倍,而426的效力是304的1/50。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号